Evidence map›Paper›PMID 27538860›Full record

ArticleComparative medicine2016

Swine (Sus scrofa) as a Model of Postinfarction Mitral Regurgitation and Techniques to Accommodate Its Effects during Surgical Repair.

Eric L Sarin, Weiwei Shi, Rajnish Duara, Todd A Melone, Kanika Kalra, Ashley Strong, Apoorva Girish, Bryant V McIver, Vinod H Thourani, Robert A Guyton and 1 more

Open access · greenAbstract read
In one paragraph

Article in Comparative medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Eric L SarinStructural Heart Disease Research and Innovation Laboratory, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Emory University, Atlanta, Georgia, USA.
Weiwei ShiStructural Heart Disease Research and Innovation Laboratory, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Emory University, Atlanta, Georgia, USA.
Rajnish DuaraStructural Heart Disease Research and Innovation Laboratory, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Emory University, Atlanta, Georgia, USA.
Todd A MeloneCardiac Perfusion Services, Emory Healthcare, Atlanta, Georgia, USA.
Kanika KalraStructural Heart Disease Research and Innovation Laboratory, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Emory University, Atlanta, Georgia, USA.
Ashley StrongStructural Heart Disease Research and Innovation Laboratory, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Emory University, Atlanta, Georgia, USA.
Apoorva GirishStructural Heart Disease Research and Innovation Laboratory, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Emory University, Atlanta, Georgia, USA.
Bryant V McIverStructural Heart Disease Research and Innovation Laboratory, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Emory University, Atlanta, Georgia, USA.
Vinod H ThouraniStructural Heart Disease Research and Innovation Laboratory, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Emory University, Atlanta, Georgia, USA.
Robert A GuytonStructural Heart Disease Research and Innovation Laboratory, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Emory University, Atlanta, Georgia, USA.
Muralidhar PadalaStructural Heart Disease Research and Innovation Laboratory, Division of Cardiothoracic Surgery, Carlyle Fraser Heart Center, Emory University, Atlanta, Georgia, USA. spadala@emory.edu.
Emory University Hospital Midtown · USEmory Healthcare · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mitral regurgitation (MR) is a common heart-valve lesion after myocardial infarction in humans. Because it is considered a risk factor for accelerated heart failure and death, various surgical approaches and catheter-based devices to correct it are in development. Lack of a reproducible animal model of MR after myocardial infarction and reliable techniques to perform open-heart surgery in these diseased models led to the use of healthy animals to test new devices. Thus, most devices that are deemed safe in healthy animals have shown poor results in human efficacy studies, hampering progress in this area of research. Here we report our experience with a swine model of postinfarction MR, describe techniques to induce regurgitation and perform open-heart surgery in these diseased animals, and discuss our outcomes, complications, and solutions.

Indexed as

AnimalsCardiac Valve AnnuloplastyCardiopulmonary BypassDisease Models, AnimalEchocardiography, Doppler, ColorFemaleFluoroscopyMitral Valve InsufficiencyModels, AnatomicMyocardial InfarctionSus scrofa

Identifiers

PMID27538860
PMCPMC4983171
OpenAlexW2520610119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.